1) nt-probnp
N-末端前体脑钠肽
1.
Objective To observe correlation among left ventricular ejection fractionin(LVEF),coagulation function and Nt-proBNP concentration of patients with chronic cardiac failure(CCF).
目的观察慢性心力衰竭(心衰)患者左室射血分数的降低与凝血功能、血浆N-末端前体脑钠肽(Nt-proBNP)浓度之间的关系。
2) N-terminal probrain natriuretic peptide(NTBNP)
脑钠肽前体N-末端肽
3) NT-proBNP
N末端脑利钠肽前体
1.
The dynamic change of NT-proBNP in patients with multiple injury at the early stage after trauma and its evaluation value of injury severity;
多发伤患者早期N末端脑利钠肽前体动态变化及其伤情评估价值
4) NT-proBNP
N-末端脑钠肽前体
1.
Application of plasma NT-proBNP in the diastolic heart failure in the elderly;
血浆N-末端脑钠肽前体在老年舒张性心力衰竭患者中的应用研究
2.
Analysis on the Changes of NT-proBNP Levels and Their Relations to Perioperative Multi-factors in Patients after Cardiac Valve Replacement;
N-末端脑钠肽前体在风心病瓣膜置换术围手术期的动态变化及其影响因素
补充资料：[3-(aminosulfonyl)-4-chloro-N-(2.3-dihydro-2-methyl-1H-indol-1-yl)benzamide]
分子式：C16H16ClN3O3S
分子量：365.5
CAS号：26807-65-8
性质：暂无
制备方法：暂无
用途：用于轻、中度原发性高血压。
分子量：365.5
CAS号：26807-65-8
性质：暂无
制备方法：暂无
用途：用于轻、中度原发性高血压。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条